Guggenheim, the eighth-largest U.S. ETF issuer, plans to lower fees on its nine equal-weight sector ETFs, according to a regulatory filing.

“At a meeting held on November 14, 2013, at the recommendation of Security Investors, LLC (the “Advisor”), the investment adviser to the Funds, the Board of Trustees (the “Board”) of Rydex ETF Trust (the “Trust”), including a majority of the Independent Trustees, approved a reduction in the advisory fee paid by the Funds to the Advisor from 0.50% to 0.40%,” according to the filing.

The new expense ratios will go into effect Dec. 1.

Guggenheim is one of the largest purveyors of equal-weight ETFs. The firm’s equal-weight crown jewel is the Guggenheim S&P Equal Weight ETF (NYSEArca: RSP), which has $5.9 billion and has risen to prominence for its consistent out-performance of the cap-weighted S&P 500. RSP is not among the Guggenheim ETFs that see its fees reduced. [Why Equal-Weight ETFs Outperform Traditional Benchmarks]

Among the nine Guggenheim equal-weight sector funds that will see lower expenses are the $134.4 million Guggenheim S&P Equal Weight Healthcare ETF (NYSEArca: RYH) and the $291.3 million Guggenheim S&P Equal Weight Technology ETF (NYSEArca: RYT).

Full List of Guggenheim Equal-Weight ETFs

The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Mr. Lydon serves as an independent trustee of certain mutual funds and ETFs that are managed by Guggenheim Investments; however, any opinions or forecasts expressed herein are solely those of Mr. Lydon and not those of Guggenheim Funds, Guggenheim Investments, Guggenheim Specialized Products, LLC or any of their affiliates. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.